维普中文期刊产品整合服务
10篇 您的检索式:作者名="John Tobin"
    题名 作者 年代 出处 被引量
1BIM技术与虚拟设计施工(VDC)——颠覆性创新的案例显示文摘原文作者时任纽约某建筑设计公司的设计总监,以自己多年亲历所在公司的BIM技术的推广和发展过程为背景,对BIM技术给整个行业所带来的影响和价值进行了深入的探讨。John Tobin 2013工程质量2013,31,4:2
2Fungal melanins and their interactions with metal显示文摘Robert V Fogarty John M Tobin 1996Enzyme and Microbial Technology1996,19,4:1
3Binding of hard and soft metal ions to Rhizopus arrhizus biomass显示文摘Joseph M. Brady John M. Tobin 1995Enzyme and Microbial Technology1995,,9:1
4Nonlinear predictive control of spacecraft 显示文摘CRASSIDIS John L MARKLEYY F Landis ANTHONY Tobin C 1997Journal of Guidance Control and Dynamics1997,20,6:1
5Dexmedetomidine-Induced Sedation in Volunteers Decreases Regional and Global Cerebral Blood Flow显示文摘Richard C. Prielipp Michael H. Wall Joseph R. Tobin Leanne Groban Mark A. Cannon Frederic H. Fahey H. Donald Gage David A. Stump Robert L. James Judy Bennett John Butterworth 2002Anesthesia & Analgesia2002,,4:1
6Iron status and exercise 显示文摘John Beard Brian Tobin 2000Nut Bioch2000,11,7:1
7Mapping of nutrient-induced biochemical changes in living algal cells using synchrotron infrared microspectroscopy显示文摘Philip Heraud Bayden R. Wood Mark J. Tobin John Beardall Don McNaughton 2005FEMS Microbiology Letters2005,,2:1
8Integrated Project Delivery:Next-Generation BIM for StructuralEngineering显示文摘Franklin D Lancaster John Tobin 2010StructuresCongress2010,,:1
9Enhancing the dissolution of phenylbutazone using Syloid based mesoporous silicas for oral equine applications显示文摘Three mesoporous silica excipients(Syloid? silicass AL-1 FP, XDP 3050 and XDP 3150) were formulated with a model drug known for its poor aqueous solubility, namely phenylbutazone, in an attempt to enhance the extent and rate of drug dissolution. Although other forms of mesoporous silica have been investigated in previous studies, the effect of inclusion with these specific Syloid? silicas based excipients and more interestingly, with phenylbutazone, is unknown. This work reports a significant enhancement for both the extent and rate of drug release for all three forms of Syloid? silicas at a 1:1 drug:silica ratio over a period of 30 min. An explanation for this increase was determined to be conversion to the amorphous form and an enhanced drug loading ability within the pores. Differences between the release profiles of the three silicas were concluded to be a consequence of the physicochemical differences between the three forms. Overall, this study confirms that Syloid? silicas based excipients can be used to enhance dissolution, and potentially therefore bioavailability, for compounds with poor aqueous solubility such as phenylbutazone. In addition, it has been confirmed that drug release can be carefully tailored based on the choice of Syloid? silicas and desired release profile.Laura J. Waters John P. Hanrahan Joseph M. Tobin Catherine V. Finch Gareth M.B. Parkes Shamsuddeen A. Ahmad Faraj Mohammad Maria Saleem 2018Journal of Pharmaceutical Analysis2018,8,3:1
10Metal-anion sorption by chitosan beads:equilibrium and kinetic studies 显示文摘GUIBAL ERIC M1LOT CELINE MICHAEL TOBIN JOHN 1998Ind Eng Chem Res1998,37,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费